8 completed. 8 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Completed 8 |
Follow FOLFOXIRI protocol: new trials by email Literature Review of FOLFOXIRI protocol trials Research Report on FOLFOXIRI protocol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Organ Preservation Program Using Short-Course Radiation & FOLFOXIRI in Rectal Cancer FOLFOXIRI, FOLFOX regimen, XELOX - Rectal Cancer | Phase 2 | Completed | Stanford University | 38 | 2020-05-21 | 2025-02-25 |
| Triplet (FOLFOXIRI) vs. Doublet (FOLFOX or FOLFIRI) Regimen as a 1st Line Treatment in Metastatic Colorectal Carcinoma FOLFOXIRI Protocol - Metastatic Colorectal Cancer | Phase 2 | Completed | Kasr El Aini Hospital | 64 | 2018-01-16 | 2022-04-07 |
| Neoadjuvant Triplet Chemotherapy Regimen in Patients With Locally Advanced Rectal Cancer FOLFOXIRI - Locally Advanced Rectal Cancer | Phase 2 | Completed | Aiping Zhou | 50 | 2016-02-06 | 2021-02-01 |
| FOLFOXIRI With or Without Bevacizumab as First-line Treatment for Unresectable Liver-only Metastatic Colorectal Cancer Patients With RAS Mutation-type FOLFOXIRI + Bevacizumab, FOLFOXIRI - Metastatic Colorectal Cancer | Phase 2 | Completed | Sun Yat-sen University | 138 | 2015-01-01 | 2026-05-22 |
| Neoadjuvant FOLFOXIRI Chemotherapy Alone for Locally Advanced Rectal Cancer FOLFOXIRI - Rectal Cancer | Phase 2 | Completed | Sun Yat-sen University | 100 | 2014-08-15 | 2021-04-14 |
| FOLFOXIRI With or Without Cetuximab as First-line Treatment of Patients With Non-resectable Liver - Only Metastatic Colorectal Cancer FOLFOXIRI + Cetuximab, FOLFOXIRI - Metastatic Colorectal Cancer | Phase 2 | Completed | Sun Yat-sen University | 101 | 2014-02-01 | 2020-03-31 |
| FOLFOXIRI as Primary Treatment for Locally Advanced Pancreatic Cancer FOLFOXIRI - Pancreatic Carcinoma Stage III | Phase 2 | Completed | Azienda Ospedaliero, Universitaria Pisana | 50 | 2012-12-01 | 2015-01-30 |
| FOLFOXIRI With or Without Panitumumab in Metastatic Colorectal Cancer (VOLFI) FOLFOXIRI + Panitumumab, FOLFOXIRI - Metastatic Colorectal Cancer | Phase 2 | Completed | AIO-Studien-gGmbH | 93 | 2011-04-01 | 2023-06-15 |
Colorectal Neoplasms (4) · Rectal Neoplasms (3) · Pancreatic Neoplasms (1)
Sun Yat-sen University (3) · AIO-Studien-gGmbH (1) · Aiping Zhou (1) · Azienda Ospedaliero, Universitaria Pisana (1) · Kasr El Aini Hospital (1) · Stanford University (1)
China (4) · Egypt (1) · Germany (1) · Italy (1) · United States (1)
Yanhong Deng, M.D. (2) · Aiping Zhou, Doctor (1) · Erqi L Pollom (1)
PMID 31609637, PMID 35834598, PMID 37370032, PMID 38902952, PMID 42743885
2009 (1)